Significant Ownership of Pivotal bioVenture Partners Fund I, L.P.

Signature - Title
By Pivotal bioVenture Partners Fund I G.P., L.P. - its General Partner
Location
San Francisco, CA
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Pivotal bioVenture Partners Fund I, L.P..

Notify me when Pivotal bioVenture Partners Fund I, L.P. files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Pivotal bioVenture Partners Fund I, L.P.

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
EVMN Evommune, Inc. Common Stock, par value $0.0001 per share 11% $69,158,608 3,435,599 Nan Fung Group Holdings Limited 31 Dec 2025
OCS Oculis Holding AG Ordinary Shares, CHF 0.01 par value per share 4.9% $49,946,544 2,815,476 Nan Fung Group Holdings Limited 30 Sep 2025
BOLT Bolt Biotherapeutics, Inc. Common Stock, $0.00001 par value 4.6% $478,373 -$222,181 87,486 -32% Nan Fung Group Holdings Limited 24 Feb 2026
INZY Inozyme Pharma, Inc. Common Stock, par value $0.0001 per share 0% $0 0 Pivotal bioVenture Partners Fund I, L.P. 01 Jul 2025

Schedules 13D/G Reported by Pivotal bioVenture Partners Fund I, L.P.:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.